» Articles » PMID: 33050089

Hyaluronic Acid in the Intestinal Tract: Influence of Structure, Rheology, and Mucoadhesion on the Intestinal Uptake in Rats

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 Oct 14
PMID 33050089
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Oral hyaluronic acid (HA) is a ubiquitous biopolymer that has gained attention as a treatment for local or systemic diseases. Here, we prepared and characterized structures of free HA (f-HA) with a high (>10 Da), intermediate (≤10 Da), and low (≤10 Da) average molar mass (MM); nanoparticles crosslinked with adipic dihydrazide (n-HA); and mixed formulations (mixed-HA) containing f-HA and n-HA. MM distribution determined the structure, hydrodynamic diameter, and zeta potential of the f-HAs. Crosslinking changed the physicochemical properties in n-HA. In vitro tack adhesion assays, using mucin tablets or a viable rat intestinal mucosa, showed better mucoadhesion with f-HA (intermediate MM) and mixed-HA (25% n-HA), especially in the jejunum segment. High MM f-HA presented negligible mucoadhesion. n-HA showed the deepest diffusion into the porous of the membranes. In vivo results showed that, except for high MM f-HA, there is an inverse relationship between rheological changes in the intestinal membrane macerates resulting from mucoadhesion and the effective intestinal permeability that led to blood clearance of the structures. We conclude that the n-HA formulations are promising for targeting other tissues, while formulations of f-HA (intermediate MM) and mixed-HA are better for treating dysbiosis.

Citing Articles

Natural Epithelial Barrier Integrity Enhancers- and Extracts.

Coopersmith S, Rahamim V, Drori E, Miloslavsky R, Kozlov R, Gorelick J Gels. 2024; 10(12).

PMID: 39727593 PMC: 11675818. DOI: 10.3390/gels10120836.


Hyaluronic Acid in Nanopharmaceuticals: An Overview.

Matalqah S, Lafi Z, Yousef Asha S Curr Issues Mol Biol. 2024; 46(9):10444-10461.

PMID: 39329973 PMC: 11431703. DOI: 10.3390/cimb46090621.


Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs.

Pratap-Singh A, Guo Y, Baldelli A, Singh A Pharmaceutics. 2023; 15(9).

PMID: 37765234 PMC: 10534625. DOI: 10.3390/pharmaceutics15092265.


New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407.

Bakhrushina E, Novozhilova E, Shumkova M, Pyzhov V, Nikonenko M, Bardakov A Gels. 2023; 9(7).

PMID: 37504387 PMC: 10379042. DOI: 10.3390/gels9070508.


New Hyaluronic Acid from Plant Origin to Improve Joint Protection-An In Vitro Study.

Galla R, Ruga S, Aprile S, Ferrari S, Brovero A, Grosa G Int J Mol Sci. 2022; 23(15).

PMID: 35897688 PMC: 9332867. DOI: 10.3390/ijms23158114.

References
1.
Fagerholm U, Nilsson D, Knutson L, Lennernas H . Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag. Acta Physiol Scand. 1999; 165(3):315-24. DOI: 10.1046/j.1365-201x.1999.00510.x. View

2.
Baranova N, Foulcer S, Briggs D, Tilakaratna V, Enghild J, Milner C . Inter-α-inhibitor impairs TSG-6-induced hyaluronan cross-linking. J Biol Chem. 2013; 288(41):29642-53. PMC: 3795262. DOI: 10.1074/jbc.M113.477422. View

3.
Zakeri-Milani P, Barzegar-Jalali M, Tajerzadeh H, Azarmi Y, Valizadeh H . Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. J Pharm Biomed Anal. 2005; 39(3-4):624-30. DOI: 10.1016/j.jpba.2005.04.008. View

4.
Rabba A, Si L, Xue K, Li M, Li G . In Situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay. J Pharm Pharm Sci. 2011; 14(2):138-47. DOI: 10.18433/j36w2j. View

5.
Toole B . Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004; 4(7):528-39. DOI: 10.1038/nrc1391. View